Selection of statistical tests considering competing risks: the importance of understanding the assumptions in each test.
作者信息
Akahoshi Yu
机构信息
Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
出版信息
Blood Adv. 2024 May 28;8(10):2571-2572. doi: 10.1182/bloodadvances.2024012711.
Abstract
摘要
相似文献
1
Selection of statistical tests considering competing risks: the importance of understanding the assumptions in each test.考虑竞争风险时统计检验的选择：理解每种检验假设的重要性。
Blood Adv. 2024 May 28;8(10):2571-2572. doi: 10.1182/bloodadvances.2024012711.
2
Communicating and understanding statistical measures when quantifying the between-group difference in competing risks.当量化竞争风险中组间差异时，沟通和理解统计措施。
Int J Epidemiol. 2023 Dec 25;52(6):1975-1983. doi: 10.1093/ije/dyad127.
3
Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.心脏病学试验中相互竞争的事件发生时间终点：一项模拟研究以说明充分统计分析的重要性。
Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10.
4
Model selection in competing risks regression.竞争风险回归中的模型选择。
Stat Med. 2013 Aug 15;32(18):3077-88. doi: 10.1002/sim.5762. Epub 2013 Feb 24.
5
Implementation of an Alternative Method for Assessing Competing Risks: Restricted Mean Time Lost.实施一种评估竞争风险的替代方法：受限平均时间损失。
Am J Epidemiol. 2022 Jan 1;191(1):163-172. doi: 10.1093/aje/kwab235.
6
Bounds on the covariate-time transformation for competing-risks survival analysis.竞争风险生存分析中协变量-时间变换的界限
Lifetime Data Anal. 2006 Sep;12(3):285-303. doi: 10.1007/s10985-006-9015-z. Epub 2006 Aug 18.
7
A global test for competing risks survival analysis.一种用于竞争风险生存分析的全球检验。
Stat Methods Med Res. 2020 Dec;29(12):3666-3683. doi: 10.1177/0962280220938402. Epub 2020 Jul 6.
8
Penalized variable selection for cause-specific hazard frailty models with clustered competing-risks data.基于聚类竞争风险数据的有向风险脆弱性模型的惩罚变量选择。
Stat Med. 2021 Dec 20;40(29):6541-6557. doi: 10.1002/sim.9197. Epub 2021 Sep 20.
9
Random survival forests for competing risks.用于竞争风险的随机生存森林
Biostatistics. 2014 Oct;15(4):757-73. doi: 10.1093/biostatistics/kxu010. Epub 2014 Apr 11.
10
Competing risks and the clinical community: irrelevance or ignorance?竞争风险与临床界：无关紧要还是一无所知？
Stat Med. 2012 May 20;31(11-12):1089-97. doi: 10.1002/sim.4384. Epub 2011 Sep 23.
引用本文的文献
1
The role of oxidative balance score in Cardiovascular-Kidney-Metabolic syndrome progression and mortality: insights from NHANES 1999-2020.氧化平衡评分在心血管-肾脏-代谢综合征进展及死亡率中的作用：来自1999 - 2020年美国国家健康与营养检查调查（NHANES）的见解
Front Nutr. 2025 Jul 1;12:1597693. doi: 10.3389/fnut.2025.1597693. eCollection 2025.
本文引用的文献
1
Fine and Gray or Cox model?Fine和Gray模型还是Cox模型？
Blood Adv. 2024 Mar 26;8(6):1420-1421. doi: 10.1182/bloodadvances.2023012157.
2
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.初发迟发性急性移植物抗宿主病的发生率、临床表现、危险因素、结局和生物标志物。
Blood Adv. 2023 Aug 22;7(16):4479-4491. doi: 10.1182/bloodadvances.2023009885.
3
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.异基因造血干细胞移植后 CMV 再激活与急性淋巴细胞白血病复发风险降低相关。
Blood Adv. 2023 Jun 27;7(12):2699-2708. doi: 10.1182/bloodadvances.2022009376.
4
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease.巨细胞病毒胃肠炎在急性移植物抗宿主病患者中的表现。
Blood Adv. 2022 Jan 25;6(2):574-584. doi: 10.1182/bloodadvances.2021005885.
5
Effect of Cytomegalovirus Reactivation With or Without Acute Graft-Versus-Host Disease on the Risk of Nonrelapse Mortality.巨细胞病毒再激活伴或不伴急性移植物抗宿主病对非复发死亡率的影响。
Clin Infect Dis. 2021 Aug 2;73(3):e620-e628. doi: 10.1093/cid/ciaa1871.
6
Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia.供者抗宿主病和供者抗白血病效应与费城染色体阳性急性淋巴细胞白血病微小残留病的相关性。
Br J Haematol. 2020 Jul;190(1):84-92. doi: 10.1111/bjh.16540. Epub 2020 Mar 2.
7
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.移植物抗白血病效应对急性淋巴细胞白血病患者生存的影响。
Blood Adv. 2019 Feb 26;3(4):670-680. doi: 10.1182/bloodadvances.2018027003.
8
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study.抢先治疗时代造血干细胞移植后巨细胞病毒载量与死亡率：一项回顾性队列研究
Lancet Haematol. 2016 Mar;3(3):e119-27. doi: 10.1016/S2352-3026(15)00289-6. Epub 2016 Feb 20.
9
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后移植物抗宿主病和移植物抗肿瘤效应。
J Clin Oncol. 2013 Apr 20;31(12):1530-8. doi: 10.1200/JCO.2012.45.0247. Epub 2013 Mar 11.
Zotero 插件